Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

CIRCULATE-US: adjuvant chemotherapy assigned from postoperative ctDNA in colon cancer

Phase 2/3 trial that assigns adjuvant chemotherapy according to whether circulating tumor DNA is detected after surgery for colon cancer. ClinicalTrials.gov lists the study as recruiting.

NRG Oncology